New PD-1 immune checkpoint mechanism driving the growth of Merkel cell carcinoma is identified by study.

Published Date: 24 Jan 2024

Immune checkpoint inhibitor therapies that block its signaling and increase T-cell activity have programmed cell death 1 (PD-1) as a major target. PD-1 inhibitors are authorized to treat a number of cancer kinds.

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Charles III, King of Kings, is Cancerous.

2.

Chemo-Free Quadruplet Shows Promise as DLBCL's First Therapy.

3.

Perioperative Anti-PD-1 in Soft-Tissue Sarcoma Boosts Disease-Free Survival

4.

Merck enhances its oncology pipeline by means of a strategic alliance with Hengrui.

5.

WHO releases new R&D landscape analyses highlighting gaps and inequities in cancer research


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot